Zentiharvest Biotech: Announcement of Board Approval for Q1 2026 Consolidated Financial Report
Key facts
- Zentiharvest Biotech: Announcement of Board Approval for Q1 2026 Consolidated Financial Report
- Zentiharvest Biotech announced that its board of directors approved the Q1 2026 consolidated financial report on May 5, 2026. Key financial indicators for the period were released, showing solid performance.
- Source: PR Times
- Date: May 5, 2026
Direct answer
Zentiharvest Biotech announced that its board of directors approved the Q1 2026 consolidated financial report on May 5, 2026. Key financial indicators for the period were released, showing solid performance.
- Citation
- Zentiharvest Biotech: Announcement of Board Approval for Q1 2026 Consolidated Financial Report (May 5, 2026), PR Times
- Source
- PR Times
- Date
- May 5, 2026
Zentiharvest Biotech announced that its board of directors approved the Q1 2026 consolidated financial report on May 5, 2026. Key financial indicators for the period were released, showing solid performance.
📋 Article Processing Timeline
- 📰 Published: May 5, 2026 at 09:00
- 🔍 Collected: May 6, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 6, 2026 at 08:53 (53 min after Collected)
1. Date of submission to or resolution by the board of directors: 2026/05/05
2. Date of approval by the audit committee: 2026/05/05
3. Reporting period for financial report or annual self-reported financial information (XXX/XX/XX~XXX/XX/XX): 2026/01/01~2026/03/31
4. Operating revenue accumulated from January 1 to the end of this period (in thousands of NTD): 869,503
5. Operating gross profit (gross loss) accumulated from January 1 to the end of this period (in thousands of NTD): 749,396
6. Operating income (loss) accumulated from January 1 to the end of this period (in thousands of NTD): 518,169
7. Net profit (net loss) before tax accumulated from January 1 to the end of this period (in thousands of NTD): 532,246
8. Net profit (net loss) for this period accumulated from January 1 to the end of this period (in thousands of NTD): 426,698
9. Net profit (loss) attributable to owners of the parent company accumulated from January 1 to the end of this period (in thousands of NTD): 426,698
10. Basic earnings (loss) per share accumulated from January 1 to the end of this period (in NTD): 4.15
11. Total assets at the end of the period (in thousands of NTD): 4,067,795
12. Total liabilities at the end of the period (in thousands of NTD): 1,391,161
13. Equity attributable to owners of the parent company at the end of the period (in thousands of NTD): 2,676,634
14. Other matters to be specified: None
Keyword: Material Information
2. Date of approval by the audit committee: 2026/05/05
3. Reporting period for financial report or annual self-reported financial information (XXX/XX/XX~XXX/XX/XX): 2026/01/01~2026/03/31
4. Operating revenue accumulated from January 1 to the end of this period (in thousands of NTD): 869,503
5. Operating gross profit (gross loss) accumulated from January 1 to the end of this period (in thousands of NTD): 749,396
6. Operating income (loss) accumulated from January 1 to the end of this period (in thousands of NTD): 518,169
7. Net profit (net loss) before tax accumulated from January 1 to the end of this period (in thousands of NTD): 532,246
8. Net profit (net loss) for this period accumulated from January 1 to the end of this period (in thousands of NTD): 426,698
9. Net profit (loss) attributable to owners of the parent company accumulated from January 1 to the end of this period (in thousands of NTD): 426,698
10. Basic earnings (loss) per share accumulated from January 1 to the end of this period (in NTD): 4.15
11. Total assets at the end of the period (in thousands of NTD): 4,067,795
12. Total liabilities at the end of the period (in thousands of NTD): 1,391,161
13. Equity attributable to owners of the parent company at the end of the period (in thousands of NTD): 2,676,634
14. Other matters to be specified: None
Keyword: Material Information
FAQ
What are the key facts in this article?
Zentiharvest Biotech announced that its board of directors approved the Q1 2026 consolidated financial report on May 5, 2026. Key financial indicators for the period were released, showing solid performance.
What is the direct answer?
Zentiharvest Biotech announced that its board of directors approved the Q1 2026 consolidated financial report on May 5, 2026. Key financial indicators for the period were released, showing solid performance.
What is the source and date?
PR Times: https://mops.twse.com.tw/material/twse-6534-2026-05-05-2b9c8d7f | May 5, 2026